| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/02/2011 | US20110129523 Liposomally Encapsulated Reduced Glutathione, including with Other Pharmacologic Preparation, Capable of Administration as an Oral, Topical, Intraoral or Transmucosal, Prepartion, for Reversal and Prevention of Oxidation of Cholesterol and of Low Density Lipoprotein |
| 06/02/2011 | US20110129522 Transdermal system for extended delivery of incretins and incretn mimetic peptides |
| 06/02/2011 | US20110129521 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 06/02/2011 | US20110129519 Modafinil-Based Treatment For Premature Ejaculation |
| 06/02/2011 | US20110129518 Probiotic products for pet applications |
| 06/02/2011 | US20110129517 Tablettable chewing gums |
| 06/02/2011 | US20110129516 Ocular drug delivery devices |
| 06/02/2011 | US20110129515 Devices and Methods for Nerve Regeneration |
| 06/02/2011 | US20110129514 Hygroscopic coating on a balloon device |
| 06/02/2011 | US20110129512 Antimicrobial Releasing Polymers |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129510 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
| 06/02/2011 | US20110129508 Methods and compositions for the management of pain using omega-conotoxins |
| 06/02/2011 | US20110129507 Controlled release formulations exhibiting an ascending rate of release |
| 06/02/2011 | US20110129506 Colouring using pearlescent pigments in the food and pharmaceutical sectors |
| 06/02/2011 | US20110129505 Cellulose derivative and hydrogel thereof |
| 06/02/2011 | US20110129504 Composition for controlling lipase catalyzed reactions |
| 06/02/2011 | US20110129426 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia |
| 06/02/2011 | US20110129417 Administrable compositions |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327754A2 Compositions containing fluorine substituted olefins |
| 06/01/2011 | EP2327753A2 Aerosol propellants comprising unsaturated fluorocarbons |
| 06/01/2011 | EP2327424A1 Novel excipient for mannitol tableting |
| 06/01/2011 | EP2327421A1 Stabilized liquid anti-RSV antibody formulations |
| 06/01/2011 | EP2327419A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327407A1 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
| 06/01/2011 | EP2327406A1 Stabilized pharmaceutical composition |
| 06/01/2011 | EP2327398A2 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 06/01/2011 | EP2327397A2 Method for manufacturing sustained release microsphere by solvent flow evaporation method |
| 06/01/2011 | EP2327396A2 Charged lipoprotein complexes and their uses |
| 06/01/2011 | EP2327395A1 Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 06/01/2011 | EP2327394A1 Liquid pharmaceutical composition |
| 06/01/2011 | EP2326331A1 Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| 06/01/2011 | EP2326326A2 Purin derivatives for use in the treatment of fab-related diseases |
| 06/01/2011 | EP2326324A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 06/01/2011 | EP2326314A1 Particle compositions with a pre-selected cell internalization mode |
| 06/01/2011 | EP2326313A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 06/01/2011 | EP2326312A1 Paliperidone composition comprising solid matrix particles |
| 06/01/2011 | EP2326311A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 06/01/2011 | EP2326310A1 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders |
| 06/01/2011 | EP2326309A2 Improvements relating to nanodisperse compositions |
| 06/01/2011 | EP2326308A2 Improvements relating to pharmaceutical compositions |
| 06/01/2011 | EP2326307A2 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
| 06/01/2011 | EP2326306A1 Liquid formulations of bendamustine |
| 06/01/2011 | EP2326305A1 Medical devices employing conductive polymers for delivery of therapeutic agents |
| 06/01/2011 | EP2326304A2 Methods for enhancing the stability of polyorthoesters and their formulations |
| 06/01/2011 | EP2326303A1 Method of standardization of injectable medicines and their diluents |
| 06/01/2011 | EP2117517B1 Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment |
| 06/01/2011 | EP1585470B1 Transdermal delivery of fentanyl |
| 06/01/2011 | EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/01/2011 | EP1169314B2 Process for the manufacture of salts of citalopram |
| 06/01/2011 | DE10203923B4 Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung A method for increasing the water solubility of lipophilic active ingredients, preparation of highly concentrated aqueous compositions of these active ingredients such products and their use |
| 06/01/2011 | CN201847947U Nose mask for preventing and curing cardiovascular and cerebrovascular diseases |
| 06/01/2011 | CN201847946U Tablet easy for dose dividing |
| 06/01/2011 | CN201847945U Tablet capable of being divided into multiple equal portions |
| 06/01/2011 | CN1927201B Antibiotic compound recipe comprising piperacillin |
| 06/01/2011 | CN1876177B Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
| 06/01/2011 | CN1857445B Quality control method for Desheng preparation |
| 06/01/2011 | CN102083972A Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 06/01/2011 | CN102083467A Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both |
| 06/01/2011 | CN102083424A Methods and use of inducing apoptosis in cancer cells |
| 06/01/2011 | CN102083423A Encapsulation of biologically active agents |
| 06/01/2011 | CN102083422A Fenofibrate formulation with enhanced oral bioavailability |
| 06/01/2011 | CN102083421A Lipid composition |
| 06/01/2011 | CN102083420A Pharmaceutical dosage form comprising polymeric carrier composition |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083418A Oral contraceptive dosage forms and methods of making such dosage forms |
| 06/01/2011 | CN102083417A Novel dosage and formulation |
| 06/01/2011 | CN102083416A Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| 06/01/2011 | CN102083415A Methods for treating herpes virus infections |
| 06/01/2011 | CN102083414A Composition comprising an antibiotic and a corticosteroid |
| 06/01/2011 | CN102083413A Method and composition for treating ocular hypertension and glaucoma |
| 06/01/2011 | CN102083412A Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration |
| 06/01/2011 | CN102083411A Carrier |
| 06/01/2011 | CN102083410A Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 06/01/2011 | CN102079761A Water-soluble S, S-heptaplatin derivative |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102078637A Sodium alginate/tamarind gum blended drug-loaded membrane as well as preparation method and application thereof |
| 06/01/2011 | CN102078636A Hydrogel dressing containing recombinant human epidermal growth factor and preparation method and application thereof |
| 06/01/2011 | CN102078619A Transdermal therapeutic preparation |
| 06/01/2011 | CN102078615A Composition of proton pump inhibitor and gastric mucosa protective agent |
| 06/01/2011 | CN102078612A Nasal in-situ gel containing mometasone furoate and H1 receptor antagonist |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078599A Compound trimebutine maleate preparation and preparation method thereof |
| 06/01/2011 | CN102078598A Injection for preventing and treating porcine viral diseases and preparation method thereof |
| 06/01/2011 | CN102078596A Application of toad peptide antibiotics in preparing drugs for treating hemorrhoids |
| 06/01/2011 | CN102078595A Application of toad peptide antibiotic for preparing medicines for curing tinea manus and pedis |
| 06/01/2011 | CN102078594A Application of toad peptide antibiotics in preparing drugs for treating anal fistula |
| 06/01/2011 | CN102078593A Application of toad peptide antibiotic for preparing medicines for curing diabetic foot |
| 06/01/2011 | CN102078592A Application of toad peptide antibiotics in preparing drugs for treating acnes |
| 06/01/2011 | CN102078589A Marrow-replenishing blood-nourishing pill |
| 06/01/2011 | CN102078587A High-efficiency tumor-eliminating pill |
| 06/01/2011 | CN102078585A Traditional Chinese medicine for treating kidney deficiency |
| 06/01/2011 | CN102078584A Traditional Chinese medicine preparation for treating hot cold |
| 06/01/2011 | CN102078583A Traditional Chinese medicine pill for treating cough |
| 06/01/2011 | CN102078576A Chinese medicine powder for treating epilepsy |
| 06/01/2011 | CN102078575A Chinese medicine powder for treating eructation |
| 06/01/2011 | CN102078568A Traditional Chinese medicine tablet for treating chronic cholecystitis |